Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INSMED Inc Director's Dealing 2024

Aug 14, 2024

30150_dirs_2024-08-14_a4396e63-5c01-416a-adff-704c74833738.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2024-08-12

Reporting Person: Schaeffer Orlov S Nicole (Chief People Strategy Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-08-12 Common Stock S 9469 $72.49 Disposed 100100 Direct

Footnotes

F1: This is the weighted average sales price representing 9,469 shares sold at prices ranging from $72.36 to $72.63 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F2: Includes 809 shares acquired through the Company's 2018 Employee Stock Purchase Plan.